Although considered a single class, fecal immunochemical tests (FITs) vary in their ability to detect advanced colorectal neoplasia (ACN) and should not be considered interchangeable, new research ...
Mailing mt-sDNA tests to Medicare Advantage enrollees improved CRC screening adherence, with a 49.4% overall adherence rate. Digital outreach, especially combining email and text, significantly ...
Please provide your email address to receive an email when new articles are posted on . A new American Cancer Society guideline has added recommendations for blood-based screening tests for CRC. The ...
WASHINGTON -- A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified sensitivity and specificity endpoints, according to results from the PREEMPT CRC study. Using ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The blood-based test identified stage I, II or III ...
BRISBANE, Calif., May 27, 2026 /PRNewswire/ -- Freenome, an early cancer detection company developing blood-based screening tests, welcomes the inclusion of blood-based testing in the American Cancer ...
A novel, blood-based test developed using fragmentomic features of cell-free DNA (cfDNA) detects colorectal cancer (CRC) with a 90.4% sensitivity and shows consistent performance across stages and ...
On May 27, the American Cancer Society published updated screening guidelines for colorectal cancer, officially adding Guardant Health’s FDA-approved Shield blood test to its list of approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results